Regionalization of ST-segment elevation myocardial infarction care: A task unfinished
Prognostic implications of troponin T and creatine kinase-MB elevation after coronary artery bypass grafting
Randomized controlled trial of ventricular elastic support therapy in the treatment of symptomatic heart failure: Rationale and design
The Study Of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale
ABSORB II randomized controlled trial
Cardiac conduction system disease after transcatheter aortic valve replacement
Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects
De Facto regionalization of care for ST-elevation myocardial infarction in Florida, 2001-2009
Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: An analysis from ACT34-CMI
Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department
Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction
Erythropoietin treatment in patients with acute myocardial infarction: A meta-analysis of randomized controlled trials
Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients—Results from the PLATelet inhibition and patient Outcomes (PLATO) study
Randomized controlled trial comparing simultaneous versus optimized sequential interventricular stimulation during cardiac resynchronization therapy
The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction
Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications
Comprehensive geriatric assessment and hospital mortality among older adults with decompensated heart failure
Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction
Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: An intra-patient comparison
Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery
Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study
Clarification of the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment (REMIT) Trial Protocol
Response to the “Clarification of the REMIT Trial Protocol”